DGAP-Adhoc: UMS AG: Management Board resolves to continue share buy-back program

 | Quelle: EQS Group AG EQS Group AG 

UMS United Medical Systems International AG  / Key word(s): Share Buyback

22.11.2010 17:43

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Hamburg, November 22th, 2010 - The Management Board of UMS United Medical
Systems AG (UMS/ISIN DE0005493654), acting with the Supervisory Board's
consent, has decided to extend the Company's share buy-back program beyond
November 30, 2010. Now the Company has until June 2, 2015 to buy back own
shares. The program's other terms and conditions will remain in force
unchanged for the duration of the extension.

The resolution is based on an authorization of the Shareholders' Meeting
dated June 3, 2010, according to which the Company is entitled pursuant to
§ 71 (1) No. 8 of the German Stock Corporation Act (AktG) to repurchase up
to 10% of its existing share capital, which is the equivalent of up to
541,464 shares with a theroretical par value of approximately EUR1,11.

As of November 22, 2010, UMS AG held 303,652 of its own shares, which
corresponds to 5.6 % of its share capital. Additional details concerning
the share buy-back program and information about repurchases made will be
published regularly on the UMS AG website at www.umsag.com.
 


Contact
Wiebke Budwasch, Tel: (040) 500 177-0, Fax: (040) 500 177-77, E-Mail:
investor@umsag.com




22.11.2010 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      UMS United Medical Systems International AG
              Borsteler Chaussee 53
              22453 Hamburg
              Deutschland
Phone:        +49 (0)40 - 500 177 - 00
Fax:          +49 (0)40 - 500 177 - 77
E-mail:       investor@umsag.com
Internet:     www.umsag.com
ISIN:         DE0005493654
WKN:          549365
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Hamburg, München, Düsseldorf, Berlin, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------